摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Trestatin B | 71869-92-6

中文名称
——
中文别名
——
英文名称
Trestatin B
英文别名
2-[5-[5-[5-[3,4-dihydroxy-6-methyl-5-[[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
Trestatin B化学式
CAS
71869-92-6
化学式
C37H63NO28
mdl
——
分子量
969.9
InChiKey
WEDWQCPYKKZMDF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -12.3
  • 重原子数:
    66
  • 可旋转键数:
    15
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.95
  • 拓扑面积:
    480
  • 氢给体数:
    20
  • 氢受体数:
    29

文献信息

  • Treatment of rumen acidosis with alpha-amylase inhibitors
    申请人:Pfizer Limited
    公开号:EP1745790A2
    公开(公告)日:2007-01-24
    Inhibitors of rumen bacterial alpha-amylase and/or alpha-glucosidase are useful in the preparation of medicaments for the curative, palliative and prophylactic treatment of rumen acidosis and secondary conditions of rumen acidosis.
    瘤胃细菌α-淀粉酶和/或α-葡萄糖苷酶抑制剂可用于制备治疗、缓解和预防瘤胃酸中毒和继发性瘤胃酸中毒的药物。
  • AMINOSUGAR COMPOUND AND PROCESS FOR PRODUCTION THEREOF
    申请人:Sasamura Satoshi
    公开号:US20110105420A1
    公开(公告)日:2011-05-05
    [Object] Disclosed is a compound useful as an active ingredient for a pharmaceutical composition having an α-amylase inhibitory activity, particularly a pharmaceutical composition for the treatment of diabetes. [Solution] An investigation has been made on a compound having an α-amylase inhibitory activity among the compounds produced by Streptomyces sp. strain 6982, which is a actinomycetes belonging to the genus Streptomyces , and it was confirmed that an aminosugar compound has an α-amylase inhibitory activity, thus completing the invention. The aminosugar compound of the present invention has an α-amylase-inhibitory activity, and therefore can be used as a prophylactic or therapeutic agent for diabetes, obesity, NASH (non-alcoholic steatohepatitis), particularly as an ameliorating agent for postprandial blood glucose elevation.
  • US7271158B2
    申请人:——
    公开号:US7271158B2
    公开(公告)日:2007-09-18
查看更多